Intracochlear drug delivery systems

Expert Opinion on Drug Delivery

Volumn 8, Issue 9, 2011, Pages 1161-1174

  Borenstein, Jeffrey T ^a  

^a CHARLES STARK DRAPER LABORATORY   (United States)

Author keywords

Computational models; Drug delivery; Hair cells; Intracochlear; Microelectronics; Microfluidics; Regeneration

Indexed keywords

NANOPARTICLE;

COCHLEA; COCHLEA PROSTHESIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; HEARING; IMPLANTABLE PORT SYSTEM; INFUSION; INNER EAR DISEASE; MICROFLUIDICS; MICROINJECTOR; NONHUMAN; OSMOTIC PUMP; REVIEW; VISCOCANALOSTOMY;

ADMINISTRATION, CUTANEOUS; ANIMALS; COCHLEA; COCHLEAR IMPLANTS; DRUG DELIVERY SYSTEMS; HUMANS; INFUSION PUMPS; INFUSIONS, PARENTERAL; LABYRINTH DISEASES; MICROFLUIDICS; MICROINJECTIONS; MINIATURIZATION; NERVE REGENERATION; PHARMACOKINETICS; TECHNOLOGY, PHARMACEUTICAL;

EID: 80052103953     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.588207     Document Type: Review

References (94)

1. Holley MC. Keynote review: The auditory system, hearing loss and potential targets for drug development. Drug Discov Today 2005;10(19):1269-82 (Pubitemid 41416699)
2. Available from: http://www.vba.va.gov/ REPORTS/abr/index.asp
3. DePalma RG, Burris DG, Champion HR, et al. Blast injuries. N Engl J Med 2005;352(13):1335-42
4. Swan EE, Mescher MJ, Sewell WF, et al. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008;60(15):1583-99
5. McCall AA, Swan EE, Borenstein JT, et al. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear 2010;31(2):156-65
6. Borkholder DA. State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg 2008;16(5):472-7
7. Theeuwes F, Yum SI. Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 1976;4(4):343-53
8. Theeuwes F, Yum SI, Haak R, et al. Systems for triggered, pulsed, and programmed drug delivery. Ann N Y Acad Sci 1991;618:428-40
9. Brown JN, Miller JM, Altschuler RA, et al. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res 1993;70(2):167-72 (Pubitemid 23353178)
10. Prieskorn DM, Miller JM. Technical report: chronic and acute intracochlear infusion in rodents. Hear Res 2000;140(1-2):212-15 (Pubitemid 30079647)
11. Silverstein H. Use of a new device, the MicroWick, to deliver medication to the inner ear. Ear Nose Throat J 1999;78(8):595-8,600
12. Silverstein H,Thompson J, Rosenberg SI, et al. Silverstein MicroWick. Otolaryngol Clin North Am 2004;37(5):1019-34 (Pubitemid 39335770)
13. Hill SL 3rd, Digges EN, Silverstein H, et al. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Menieres disease. Ear Nose Throat J 2006;85(8):494,496,498
14. Borkholder DA, Zhu X, Hyatt BT, et al. Murine intracochlear drug delivery: reducing concentration gradients within the cochlea. Hear Res 2010;268(1-2):2-11.
15. Chen Z, Kujawa SG, McKenna MJ, et al. Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release 2005;110(1):1-19 (Pubitemid 41713927)
16. Fiering J, Mescher MJ, Swan EEL, et al. Local drug delivery with a self-contained, programmable, microfluidic system. Biomed Microdevices 2009;11(3):571-8
17. Sewell WF, Borenstein JT, Chen Z, et al. Development of a microfluidics-based intracochlear drug delivery device. Audiol Neurootol 2009;14(6):411-22.
18. Pararas EEL, Chen Z, Fiering J, et al. Kinetics of reciprocating drug delivery to the inner ear. J Controlled Release 6 March 2011 [Epub ahead of print] doi:10.1016/j.jconrel.2011.02.021
19. Garnham C, Reetz G, Jolly C, et al. Drug delivery to the cochlea after implantation: consideration of the risk factors. Cochlear Implants Int 2005;6(Suppl 1):12-14 (Pubitemid 41701097)
20. Hochmair I, Nopp P, Jolly C, et al. MED-EL Cochlear implants: state of the art and a glimpse into the future. Trends Amplif 2006;10(4):201-19
21. Shepherd RK, Xu J. A multichannel scala tympani electrode array incorporating a drug delivery system for chronic intracochlear infusion. Hear Res 2002;172(1-2):92-8 (Pubitemid 35299958)
22. Schuknecht H. Pathology of the ear. Lea and Febiger, Malvern, PA; 1993
23. Staecker H. Broadening the spectrum of treatment options for SNHL. Arch Otolaryngol Head Neck Surg 2005;131(8):734 (Pubitemid 41186899)
24. Medina JE, Drescher DG. The amino-acid content of perilymph and cerebrospinal fluid from guinea-pigs and the effect of noise on the amino-acid composition of perilymph. Neuroscience 1981;6(3):505-9
25. Scheibe F, Haupt H. Biochemical differences between perilymph, cerebrospinal fluid and blood plasma in the guinea pig. Hear Res 1985;17(1):61-6 (Pubitemid 15103701)
26. Swan EE, Peppi M, Chen Z, et al. Proteomics analysis of perilymph and cerebrospinal fluid in mouse. Laryngoscope 2009;119(5):953-8
27. Banfai P, Hortmann G, Kubik S, et al. Projection of the spiral cochlear canal on the medial wall of the tympanic cavity with regard to the cochlear implant. Scand Audiol Suppl 1979;11:157-70
28. Adunka OF, Radeloff A, Gstoettner WK, et al. Scala tympani cochleostomy II: topography and histology. Laryngoscope 2007;117(12):2195-200 (Pubitemid 351339596)
29. Conn MP. Sourcebook of models for biomedical research. Chapter 32. Springer, New York; 2007
30. Telischi FF, Widick MP, Lonsbury-Martin BL, et al. Monitoring cochlear function intraoperatively using distortion product otoacoustic emissions. Am J Otol 1995;16(5):597-608
31. Telischi FF, Stagner B, Widick MP, et al. Distortion-product otoacoustic emission monitoring of cochlear blood flow. Laryngoscope 1998;108(6):837-42 (Pubitemid 28299900)
32. Gouveris H, Mann W. Association between surgical steps and intraoperative auditory brainstem response and electrocochleography waveforms during hearing preservation vestibular schwannoma surgery. Eur Arch Otorhinolaryngol 2009;266(2):225-9
33. Salt AN, Plontke SK. Principles of local drug delivery to the inner ear. Audiol Neurootol 2009;14(6):350-60
34. Littman T, Bobbin RP, Fallon M, et al. The quinoxalinediones DNOX, CNOX and two related congeners suppress hair cell-to-auditory nerve transmission. Hear Res 1989;40(1-2):45-53
35. Sendowski I, Abaamrane L, Raffin F, et al. Therapeutic efficacy of intra-cochlear administration of methylprednisolone after acoustic trauma caused by gunshot noise in guinea pigs. Hear Res 2006;221(1-2):119-27 (Pubitemid 44485381)
36. Lynch ED, Kil J. Compounds for the prevention and treatment of noise-induced hearing loss. Drug Discov Today 2005;10(19):1291-8 (Pubitemid 41416701)
37. Chiu LL, Cunningham LL, Raible DW, et al. Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 2008;9(2):178-90
38. Rybak LP, Kelly T. Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg 2003;11(5):328-33 (Pubitemid 37176002)
39. Rybak LP. Cis-platinum associated hearing loss. J Laryngol Otol 1981;95(7):745-7 (Pubitemid 11058823)
40. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today 2005;10(19):1313-21 (Pubitemid 41416704)
41. Bhandare N, Antonelli PJ, Morris CG, et al. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007;67(2):469-79 (Pubitemid 46108326)
42. Jereczek-Fossa BA, Zarowski A, Milani F, et al. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003;29(5):417-30 (Pubitemid 37185108)
43. Himeno C, Komeda M, Izumikawa M, et al. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002;167(1-2):61-70 (Pubitemid 34756851)
44. Ryan AF, Harris JP, Keithley EM, et al. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl 2002;548:38-43 (Pubitemid 34913453)
45. Yang GS, Song HT, Keithley EM, et al. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am J Otol 2000;21(4):499-504 (Pubitemid 30432457)
46. Matteson EL, Fabry DA, Strome SE, et al. Autoimmune inner ear disease: diagnostic and therapeutic approaches in a multidisciplinary setting. J Am Acad Audiol 2003;14(4):225-30
47. Mosnier I, Bouccara D, Atassi-Dumont M, et al. Treatments of idiopathic sudden sensorineural hearing loss: retrospective study of 144 cases]. Rev Laryngol Otol Rhinol (Bord) 1998;119(2):119-28 (Pubitemid 28366242)
48. Kopke RD, Hoffer ME, Wester D, et al. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001;22(4):475-9 (Pubitemid 32661944)
49. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22(1):18-23 (Pubitemid 32182848)
50. Harner SG, Driscoll CL, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Menieres syndrome. Otol Neurotol 2001;22(2):210-14 (Pubitemid 32233476)
51. Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin therapy for Menieres disease: a meta-analysis. Otol Neurotol 2004;25(4):544-52 (Pubitemid 39079778)
52. Hoffer ME, Wester D, Kopke RD, et al. Transtympanic management of tinnitus. Otolaryngol Clin North Am 2003;36(2):353-8 (Pubitemid 36529950)
53. Licameli G, Johnston P, Luz J, et al. Phosphorylcholine-coated antibiotic tympanostomy tubes: are post-tube placement complications reduced? Int J Pediatr Otorhinolaryngol 2008;72(9):1323-8
54. Plontke S, Lowenheim H, Preyer S, et al. Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials. Acta Otolaryngol 2005;125(8):830-9 (Pubitemid 41224102)
55. Available from: http://clinicaltrials.gov/ ct2/show/NCT01084525
56. Tamura T, Kita T, Nakagawa T, et al. Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 2005;115(11):2000-5 (Pubitemid 44391664)
57. Ge X, Jackson RL, Liu J, et al. Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol Head Neck Surg 2007;137(4):619-23 (Pubitemid 47445891)
58. Wareing M, Mhatre AN, Pettis R, et al. Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res 1999;128(1-2):61-9 (Pubitemid 29083246)
59. Saltzman WM. Engineering principles for drug delivery. Oxford, New York; 2001
60. Endo T, Nakagawa T, Kita T, et al. Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005;115(11):2016-20 (Pubitemid 44391667)
61. Arnold W, Senn P, Hennig M, et al. Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurootol 2005;10(1):53-63 (Pubitemid 40069615)
62. Ito J, Endo T, Nakagawa T, et al. A new method for drug application to the inner ear. ORL J Otorhinolaryngol Relat Spec 2005;67(5):272-5 (Pubitemid 43004458)
63. Nakagawa T, Sakamoto T, Hiraumi H, et al. Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Med 2010;8:76
64. Kingma GG, Miller JM, Myers MW, et al. Chronic drug infusion into the scala tympani of the guinea pig cochlea. J Neurosci Methods 1992;45(1-2):127-34
65. Carvalho GJ, Lalwani AK. The effect of cochleostomy and intracochlear infusion on auditory brain stem response threshold in the guinea pig. Am J Otol 1999;20(1):87-90 (Pubitemid 29180064)
66. Wang J, Lloyd Faulconbridge RV, Fetoni A, et al. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology 2003;45(3):380-93 (Pubitemid 36836134)
67. Praetorius M, Baker K, Brough DE, et al. Pharmacodynamics of adenovector distribution within the inner ear tissues of the mouse. Hear Res 2007;227(1-2):53-8 (Pubitemid 46590601)
68. Oestreicher E, Arnold W, Ehrenberger K, et al. New approaches for inner ear therapy with glutamate antagonists. Acta Otolaryngol 1999;119(2):174-8 (Pubitemid 29177063)
69. Stover T, Yagi M, Raphael Y, et al. Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res 1999;136(1-2):124-30 (Pubitemid 29450504)
70. Plontke SK, Siedow N, Wegener R, et al. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol Neurootol 2007;12(1):37-48 (Pubitemid 44967985)
71. Mescher MJ, Swan EE, Fiering J, et al. Fabrication methods and performance of low-permeability microfluidic components for a miniaturized wearable drug delivery system. J Microelectromech Syst 2009;18(3):501-10
72. Handzel O, Wang H, Fiering J, et al. Mastoid cavity dimensions and shape: method of measurement and virtual fitting of implantable devices. Audiol Neurootol 2009;14(5):308-14
73. Pettingill LN, Richardson RT, Wise AK, et al. Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system. IEEE Trans Biomed Eng 2007;54(6 Pt 1):1138-48 (Pubitemid 46815124)
74. Paasche G, Gibson P, Averbeck T, et al. Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol 2003;24(2):222-7 (Pubitemid 36337132)
75. Briggs RJ, Tykocinski M, Xu J, et al. Comparison of round window and cochleostomy approaches with a prototype hearing preservation electrode. Audiol Neurootol 2006;11(Suppl 1):42-8 (Pubitemid 44629842)
76. Incesulu A, Nadol JB Jr. Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 1998;107(11 Pt 1):906-11
77. Warnecke A, Wissel K, Hoffman A, et al. The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells. Neuroreport 2007;18(16):1683-6 (Pubitemid 47549134)
78. Miller JM, Le Prell CG, Prieskorn DM, et al. Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J Neurosci Res 2007;85(9):1959-69 (Pubitemid 47051484)
79. Richardson RT, Wise AK, Thompson BC, et al. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 2009;30(13):2614-24
80. Ibrahim HN, Bossard D, Jolly C, et al. Radiologic study of a disposable drug delivery ntracochlear catheter. Otol Neurotol 2011;32(2):217-22
81. Paasche G, Bogel L, Leinung M, et al. Substance distribution in a cochlea model using different pump rates for cochlear implant drug delivery electrode prototypes. Hear Res 2006;212(1-2):74-82 (Pubitemid 43254938)
82. Staecker H, Jolly C, Garnham C, et al. Cochlear implantation: an opportunity for drug development. Drug Discov Today 2010;15(7-8):314-21
83. Radeloff A, Unkelbach MH, Mack MG, et al. A coated electrode carrier for cochlear implantation reduces insertion forces. Laryngoscope 2009;119(5):959-63
84. Salt AN. Pharmacokinetics of drug entry into Cochlear Fluids. Volta Rev 2005;105(3):277-98 (Pubitemid 43876025)
85. Plontke SK, Salt AN. Simulation of application strategies for local drug delivery to the inner ear. ORL J Otorhinolaryngol Relat Spec 2006;68(6):386-92 (Pubitemid 44631668)
86. Salt AN, Plontke SK. Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today 2005;10(19):1299-306 (Pubitemid 41416702)
87. Plontke SK, Salt AN. Quantitative interpretation of corticosteroid pharmacokinetics in inner fluids using computer simulations. Hear Res 2003;182(1-2):34-42 (Pubitemid 37013281)
88. Salt AN. Simulation of methods for drug delivery to the cochlear fluids. Adv Otorhinolaryngol 2002;59:140-8
89. Maillefer D, Gamper S, Frehner B, et al. A high-performance silicon micropump for disposable drug delivery systems. IEEE MEMS 01, IEEE Press; 2001
90. Darby SG, Moore MR, Friedlander TA, et al. A metering rotary nanopump for microfluidic systems. Lab Chip 2010;10(23):3218-26
91. Abe C, Tashiro T, Tanaka K, et al. A novel type of implantable and programmable infusion pump for small laboratory animals. J Pharmacol Toxicol Methods 2009;59(1):7-12
92. Cao L, Mantell S, Polla D, et al. Design and simulation of an implantable medical drug delivery system using microelectromechanical systems technology. Sensors and Actuators A 2001;94:117-25 (Pubitemid 32997670)
93. Nguyen QT, Schroeder LF, Mank M, et al. An in vivo biosensor for neurotransmitter release and in situ receptor activity. Nat Neurosci 2010;13(1):127-32
94. Tierney S, Falch BM, Hjelme DR, et al. Determination of glucose levels using a functionalized hydrogel-optical fiber biosensor: toward continuous monitoring of blood glucose in vivo. Anal Chem 2009;81(9):3630-6